Last updated: 2026-10-16 10:12:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
AtaiBeckley Inc. (ATAI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
AtaiBeckley Inc. (ATAI) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing ATAI before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, AtaiBeckley Inc. (ATAI) moved from $7.35 to $7.35, representing no net price change.
The stock traded between $7.23 and $7.43 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 26.92 million shares, up versus the previous seven-day period, indicating higher trading activity.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 99 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AtaiBeckley Inc. (ATAI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.